在药物管制控制和执行薄弱的国家假药的存在更为普遍。
The presence of fake drugs is more prevalent in countries with weak drug regulation control and enforcement.
可是,药物管制虽然如此严格,人们还在想尽一切办法。
However, despite these restrictions, people are still acquiring it.
mOPV1将在法国和埃及药物管制机构的监督下进行生产和批准。
The mOPV1 will be produced and licensed under the oversight of the drugs regulatory agencies of France and Egypt.
One even might go so far as to say that it could be a controlled substance.
其中有一种甚至到目前为止,还是受管制药物
应用推荐